Kevin T. Nead, University of Pennsylvania School of Medicine (IMAGE)

University of Pennsylvania School of Medicine

Kevin T. Nead, University of Pennsylvania School of Medicine

Caption

Men taking androgen deprivation therapy for prostate cancer were almost twice as likely to be diagnosed with Alzheimer's disease in the years that followed than those who didn't undergo the therapy, an analysis of medical records from two large hospital systems by Penn Medicine and Stanford University researchers has shown.

Credit

Penn Medicine

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.